Kosanovic D, Kaulen C, Cornitescu T, Savai R, Hoffmann J, Reiss

Kosanovic D, Kaulen C, Cornitescu T, Savai R, Hoffmann J, Reiss I, Ghofrani HA, Weissmann N, Kuebler WM, Seeger W, Grimminger F, Schermuly RT: Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats. Respir Res 2011, 12:60. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D: Improved interleukin-1 and interleukin-6 serum concentrations in serious primary pulmonary hypertension. Am J Respir Crit Care Med 1995, 151:1628631. Bhargava A, Kumar A, Yuan N, Gewitz MH, Mathew R: Monocrotaline induces interleukin-6 mRNA expression in rat lungs. Heart Dis 1999, 1:12632. Gillespie MN, Goldblum SE, Cohen DA, McClain CJ: Interleukin 1 bioactivity in the lungs of rats with monocrotaline-induced pulmonary hypertension. Proc Soc Exp Biol Med 1988, 187:262. Dorfmuller P, Zarka V, Durand-Gasselin I, Monti G, Balabanian K, Garcia G, Capron F, Coulomb-Lhermine A, Marfaing-Koka A, Simonneau G, Emilie D, Humbert M: Chemokine RANTES in extreme pulmonary arterial hypertension. Am J Respir Crit Care Med 2002, 165:53439. Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Gerald S, Adnot S, Eddahibi S: Role of endothelium-derived CC chemokine ligand two in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2007, 176:1041047. Balabanian K, Foussat A, Dorfmuller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krzysiek R, Rimaniol AC, Simonneau G, Emilie D, Humbert M: CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 2002, 165:1419425. Perros F, Dorfmuller P, Souza R, Durand-Gasselin I, Mussot S, Mazmanian M, Herve P, Emilie D, Simonneau G, Humbert M: Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J 2007, 29:46268. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF: The best ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009, 135:79404. Dorfmuller P, Chaumais MC, Giannakouli M, Durand-Gasselin I, Raymond N, Fadel E, Mercier O, Charlotte F, Montani D, Simonneau G, Humbert M, Perros F: Elevated oxidative strain and serious arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension. Respir Res 2011, 12:119. Tabima DM, Frizzell S, Gladwin MT: Reactive oxygen and nitrogen species in pulmonary hypertension. Cost-free Radic Biol Med 2012, 52:1970986. DeMarco VG, Habibi J, Whaley-Connell AT, Schneider RI, Heller RL, Bosanquet JP, Hayden MR, Delcour K, Cooper SA, Andresen BT, Sowers JR, Dellsperger KC: Oxidative pressure contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.Mucicarmine Epigenetics Am J Physiol Heart Circ Physiol 2008, 294:H2659 2668.(-)-Catechin gallate custom synthesis Hsu HH, Ko WJ, Hsu JY, Chen JS, Lee YC, Lai IR, Chen CF: Simvastatin ameliorates established pulmonary hypertension via a heme oxygenase-1 dependent pathway in rats.PMID:24059181 Respir Res 2009, 10:32. Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, Voelkel NF: Oxidative strain in extreme pulmonary hypertension. Am J Respir Crit Care Med 2004, 169:76469. Cracowski JL, Degano B, Chabot F, Labarere J, Schwedhelm E, Monneret D, Iuliano L, Schwebel C, Chaouat A, Reynaud-Gaubert M, Faure P, Maas R, Renversez JC, Cracowski C, Sitbon O, Ya i A, Simonneau G, Humbert M:Chaumais et al. Respiratory Study 2014, 15:65 http://respiratory-research/content/15/1/Page 9 of23. 24. 25.26.27.28.29.30.31.32.